Skip to main content
Top
Published in: Respiratory Research 1/2022

01-12-2022 | Idiopathic Pulmonary Fibrosis | Research

Air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in Beijing: a time-series study

Authors: Lirong Liang, Yutong Cai, Baolei Lyu, Di Zhang, Shuilian Chu, Hang Jing, Kazem Rahimi, Zhaohui Tong

Published in: Respiratory Research | Issue 1/2022

Login to get access

Abstract

Background

A small number of studies suggested that air pollution was associated with idiopathic pulmonary fibrosis (IPF) exacerbation, incidence and mortality. However, no studies to date were conducted in regions where air pollution is substantial. We aimed to investigate whether there are associations between acute increases in air pollution and hospitalization of patients with a confirmed primary diagnosis of IPF in Beijing.

Methods

Daily count of IPF hospitalizations (International Classification of Disease-10th Revision, J84.1) was obtained from an administrative database for 2013–2017 while daily city-wide average concentrations of PM10, PM2.5, NO2, Ozone, SO2 were obtained from 35 municipal monitoring stations for the same period. The association between daily IPF hospitalization and average concentration of each pollutant was analyzed with a generalized additive model estimating Poisson distribution.

Results

Daily 24-h mean PM2.5 concentration during 2013–2017 was 76.7 μg/m3. The relative risk (RR) of IPF hospitalization per interquartile range (IQR) higher (72 μg/m3) in PM2.5 was 1.049 (95% CI 1.024–1.074) and 1.031 (95% CI 1.007–1.056) for lag0 and moving averages 0–1 days respectively. No significant associations were observed for other lags. Statistically significant positive associations were also observed at lag0 with SO2, Ozone and NO2 (in men only). Positive associations were seen at moving averages 0–30 days for PM10 (RR per 86 μg/m3: 1.021, 95% CI 0.994–1.049), NO2 (RR per 30 μg/m3: 1.029, 95% CI 0.999–1.060), and SO2 (RR per 15 μg/m3: 1.060 (95% CI 1.025–1.097), but not with PM2.5 or Ozone.

Conclusions

Despite improvement in air quality since the implementation of clean air policy in 2013, acute exposure to higher levels of air pollution is significantly associated with IPF hospitalization in Beijing. Air quality policy should be continuously enforced to protect vulnerable IPF populations as well as the general public.
Appendix
Available only for authorised users
Literature
19.
go back to reference Xie W, Li G, Zhao D, et al. Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality. Heart. 2015;101(4):257–63.CrossRefPubMed Xie W, Li G, Zhao D, et al. Relationship between fine particulate air pollution and ischaemic heart disease morbidity and mortality. Heart. 2015;101(4):257–63.CrossRefPubMed
20.
go back to reference Wang M, Wang S, Wang X, et al. The association between PM(2.5) exposure and daily outpatient visits for allergic rhinitis: evidence from a seriously air-polluted environment. Int J Biometeorol. 2020;64(1):139–44.CrossRefPubMed Wang M, Wang S, Wang X, et al. The association between PM(2.5) exposure and daily outpatient visits for allergic rhinitis: evidence from a seriously air-polluted environment. Int J Biometeorol. 2020;64(1):139–44.CrossRefPubMed
21.
go back to reference Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194:265–75.CrossRefPubMed Collard HR, Ryerson CJ, Corte TJ, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194:265–75.CrossRefPubMed
25.
go back to reference Zíková N, Wang Y, Yang F, et al. On the source contribution to Beijing PM25 concentrations. Atmos Environ. 2016;134:84–95.CrossRef Zíková N, Wang Y, Yang F, et al. On the source contribution to Beijing PM25 concentrations. Atmos Environ. 2016;134:84–95.CrossRef
29.
go back to reference Huang J, Pan X, Guo X, et al. Health impact of China’s air pollution prevention and control action plan: an analysis of national air quality monitoring and mortality data. Lancet Planet Heal. 2018;2(7):e313–23.CrossRef Huang J, Pan X, Guo X, et al. Health impact of China’s air pollution prevention and control action plan: an analysis of national air quality monitoring and mortality data. Lancet Planet Heal. 2018;2(7):e313–23.CrossRef
30.
go back to reference Zheng Y, Xue T, Zhang Q, et al. Air quality improvements and health benefits from China’s clean air action since 2013. Environ Res Lett. 2017;12(11):114020.CrossRef Zheng Y, Xue T, Zhang Q, et al. Air quality improvements and health benefits from China’s clean air action since 2013. Environ Res Lett. 2017;12(11):114020.CrossRef
Metadata
Title
Air pollution and hospitalization of patients with idiopathic pulmonary fibrosis in Beijing: a time-series study
Authors
Lirong Liang
Yutong Cai
Baolei Lyu
Di Zhang
Shuilian Chu
Hang Jing
Kazem Rahimi
Zhaohui Tong
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2022
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-022-01998-8

Other articles of this Issue 1/2022

Respiratory Research 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.